Human/SARS-CoV-2 genome-scale metabolic modeling to discover potential antiviral targets for COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) has caused a substantial increase in mortality and economic and social disruption. The absence of US Food and Drug Administration–approved drugs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the need for new therapeutic dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng-Sheng, Chen, Ke-Lin, Chu, Sz-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843340/
https://www.ncbi.nlm.nih.gov/pubmed/35186172
http://dx.doi.org/10.1016/j.jtice.2022.104273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843340/
https://www.ncbi.nlm.nih.gov/pubmed/35186172
http://dx.doi.org/10.1016/j.jtice.2022.104273

Ejemplares similares